| http://dbpedia.org/ontology/abstract
|
Bionor Holding AS is a Norwegian biotechno … Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie. in protein and lipid research, Lars Høie.
|
| http://dbpedia.org/ontology/assets
|
253.0
|
| http://dbpedia.org/ontology/equity
|
203.0
|
| http://dbpedia.org/ontology/foundingDate
|
"1993-01-02"^^xsd:date
|
| http://dbpedia.org/ontology/foundingYear
|
1993
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Oslo +
, http://dbpedia.org/resource/Norway +
|
| http://dbpedia.org/ontology/netIncome
|
49.0
|
| http://dbpedia.org/ontology/numberOfEmployees
|
18
|
| http://dbpedia.org/ontology/operatingIncome
|
46.0
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Soy_protein +
, http://dbpedia.org/resource/Health_care +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Natural_Health_Products +
|
| http://dbpedia.org/ontology/revenue
|
1.09499E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Bionor_Pharma_logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Aksjeselskap +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.bionorholding.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
39294179
|
| http://dbpedia.org/ontology/wikiPageLength
|
8721
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1106258173
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/HIV +
, http://dbpedia.org/resource/Health_care +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1993 +
, http://dbpedia.org/resource/Celgene +
, http://dbpedia.org/resource/Soy_protein +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Orkla_Group +
, http://dbpedia.org/resource/Norwegian_krone +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Oslo_Stock_Exchange +
, http://dbpedia.org/resource/Influenza +
, http://dbpedia.org/resource/CIS_countries +
, http://dbpedia.org/resource/Oslo +
, http://dbpedia.org/resource/Aksjeselskap +
, http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/Category:Companies_based_in_Oslo +
, http://dbpedia.org/resource/Category:Norwegian_brands +
, http://dbpedia.org/resource/Natural_Health_Products +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1993 +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Dr.philos. +
, http://dbpedia.org/resource/Cand.med. +
, http://dbpedia.org/resource/Norway +
, http://dbpedia.org/resource/Russia +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Norway +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Norwegian_companies_established_in_1993 +
|
| http://dbpedia.org/property/assets
|
NOK 253 395 million
|
| http://dbpedia.org/property/equity
|
NOK 203 320 million
|
| http://dbpedia.org/property/foundation
|
"1993-01-02"^^xsd:date
|
| http://dbpedia.org/property/homepage
|
https://www.bionorholding.com +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Birger Sørensen , Dag Arne Wivelstad, Aslak Aslaksen, Per Bengtsson
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Norway +
, http://dbpedia.org/resource/Oslo +
|
| http://dbpedia.org/property/logo
|
Bionor Pharma logo.png
|
| http://dbpedia.org/property/name
|
Bionor Holding AS
|
| http://dbpedia.org/property/netIncome
|
NOK 49 020 million
|
| http://dbpedia.org/property/numEmployees
|
18
|
| http://dbpedia.org/property/operatingIncome
|
NOK 46 057 million
|
| http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Natural_Health_Products +
, http://dbpedia.org/resource/Soy_protein +
, http://dbpedia.org/resource/Health_care +
, http://dbpedia.org/resource/Vaccine +
|
| http://dbpedia.org/property/revenue
|
1.09499E8
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Aksjeselskap +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1993 +
, http://dbpedia.org/resource/Category:Norwegian_companies_established_in_1993 +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Oslo_Stock_Exchange +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1993 +
, http://dbpedia.org/resource/Category:Companies_based_in_Oslo +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Norway +
, http://dbpedia.org/resource/Category:Norwegian_brands +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.476112.7 +
, http://www.grid.ac/institutes/grid.457553.5 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Bionor_Pharma?oldid=1106258173&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Bionor_Pharma_logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.bionorholding.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Bionor_Pharma +
|
| http://xmlns.com/foaf/0.1/name
|
Bionor Holding AS
|
| owl:sameAs |
https://global.dbpedia.org/id/Juhv +
, http://dbpedia.org/resource/Bionor_Pharma +
, http://fa.dbpedia.org/resource/%D8%A8%DB%8C%D9%88%D9%86%D9%88%D8%B1_%D9%81%D8%A7%D8%B1%D9%85%D8%A7 +
, http://yago-knowledge.org/resource/Bionor_Pharma +
, http://no.dbpedia.org/resource/Bionor_Pharma +
, http://www.wikidata.org/entity/Q12646423 +
, http://rdf.freebase.com/ns/m.0cqly71 +
|
| rdf:type |
http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1993 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheOsloStockExchange +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInOslo +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://dbpedia.org/class/yago/Organization108008335 +
|
| rdfs:comment |
Bionor Holding AS is a Norwegian biotechno … Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie. in protein and lipid research, Lars Høie.
|
| rdfs:label |
Bionor Pharma
|
